Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial

Diabetes Obesity and Metabolism(2020)10.1111/dom.14252Source: DataRank Database

Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial is a research paper published in Diabetes Obesity and Metabolism (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.26)OA: hybridTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Jasper Stevens ORCID,George L. Bakris ORCID,Ricardo Correa‐Rotter,Fan Fan Hou ORCID,Dalane W. Kitzman ORCID

Live enrichment

PubMed:33184931 PMC:PMC7839558 OpenAlex:https://openalex.org/W3106244848

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Grant: 917.15.306

Novo Nordisk UK Research Foundation

Grant: NNF OC0013659

Novo Nordisk Fonden

Grant: NNF14OC0013659

FWCI

1.26

Citation Percentile

0.8%

Influential Citations

Citation Trend

2020

2021

2022

2023

2024

hybridLicense: cc-by-nc

journalhttps://dom-pubs.onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14252

HYBRIDhttps://doi.org/10.1111/dom.14252

publisherhttps://dom-pubs.onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14252

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14252

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/dom.14252

Fields of Study

Chronic Kidney Disease and DiabetesAcute Kidney Injury ResearchDialysis and Renal Disease ManagementMedicineAlbuminuriaAtrasentanDiabetes Mellitus, Type 2Diabetic NephropathiesDouble-Blind MethodGlomerular Filtration RateHumansKidney

MeSH Terms

AtrasentanAlbuminuriaDiabetes Mellitus, Type 2Diabetic NephropathiesDouble-Blind MethodGlomerular Filtration RateHumansKidney

Keywords

MedicinePost-hoc analysisPost hocSonarPharmacologyInternal medicineOceanographyGeologyAtrasentan, Diabetic Kidney Disease, Endothelin Receptor Antagonist, Pharmacodynamics, Randomized Controlled Trial

Sustainable Development Goals

SDG 0: Good health and well-being

Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial

FAIR Checklist

Authors (14)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)